Aurora Cannabis’s (ACB:CSE) Marijuana Plants Start Flowering
AURORA COMMENCES FLOWERING OF 2400 MEDICINAL CANNABIS PLANTS CONSISTING OF 7 STRAINS
2015-04-28 – News Release -Aurora Cannabis Inc.’s 2,400 clones of seven different strains have been moved to the flowering stage. Commonly used names for the strains are Purple Kush, Agent Orange, Girl Scout Cookies, LSD, Strawberry Cough, AK47 and Exodus Cheese. Patients can be assured that the variety of strains will address a wide range of needs. More strains will be introduced as production ramps up. Aurora is expecting the first harvest to occur towards the end of June, 2015. Once in full production, the facility will be harvesting approximately 2500 plants every 7 days that will result in up to 100 kg of product per harvest.
Aurora’s patient acquisition plan is in the process of being finalized and the Company is confident that it will establish a significant customer base for sales while ensuring that our patients are not compromised by product shortages. This is an exciting time for Aurora and its shareholders as Aurora will begin producing a steady stream of revenue through the sales of its expertly cultivated and safe artisanal medical cannabis to customers across Canada.
Inspectors of Health Canada’s Office of Controlled Substances have visited Aurora twice since the cultivation license was issued (March 25 and April 21) and were satisfied with the facility, procedures and the progress thus far. The successful outcome of these and previous inspections continues to demonstrate Aurora’s commitment to operating successfully in this developing branch of the pharmaceutical industry. Further, in keeping to its vision of producing artisanal medical-grade cannabis, Aurora is proceeding forward with production under a unique advisory relationship designed to expand and augment each strain’s unique medical potential. This relationship was recently secured via an audit performed in California by Aurora’s quality control team.
Aurora is pleased to announce that it has entered into a contract with Ample Organics to obtain, utilize, and be supported by their advanced seed to sale enterprise resource planning (ERP) software platform for cultivation and sales of medical cannabis and medical cannabis related products. The software will enhance Aurora’s recordkeeping, traceability and overall efficiency in all aspects of facility operations. The progressive software will also help ensure that Aurora is operating as a leader in this expanding industry with only the most innovative solutions and products being made available to its future patients.
John Prentiss, CEO of Ample Organics, stated, “Ample Organics could not be more excited to have the privilege of working with the talented and experienced team at Aurora. Their purpose-built, state- of-the-art facility will now be powered by the most comprehensive software solution available today. We firmly believe that this partnership will set the bar thus further defining the Aurora Standard as the leader in this nascent industry, resulting in the best client experience in the cannabis space at every level.”
Aurora has also entered into a contract to employ the services of MMJ Hype, a division of Triforce Media Inc., a full service cannabis-marketing agency that is dedicated to providing Aurora with the highest quality search engine optimization (SEO), social media, marketing, reputation management and web analytics in the industry. Maxwell Duchaine commented, “MMJ Hype is looking forward to working with Aurora on generating additional website traffic from search engines and increasing brand awareness across Canada. MMJ Hype and Triforce Media will leverage the latest digital marketing tactics to ensure a leading position within this burgeoning industry.”
Aurora has entered into 11 non-disclosure agreements including 4 in the United States to review in detail additional synergistic opportunities within the cannabis space. Terry Booth, CEO of Aurora, commented: “The opportunities in the Cannabis industry are plentiful. It is imperative that we stay on point and focus on our strategy which is inherent to our strengths and talents.”
Aurora is the gold sponsor of the upcoming Jacob Securities Inc. investment event. Jacob Securities is a Toronto based, independent full-service investment bank, providing underwriting and financial advisory services to companies in the power, infrastructure, technology, energy and mining sectors. The event has attracted investors from around the world. Leslie Bocskor of Electrum Partners and Terry Booth, CEO of Aurora, will be guest speakers at the event.
In addition to the Jacobs investor conference, Aurora is proud to be a part of the upcoming Canadian Securities Exchange event hosted on May 6th in Calgary. The “TakeStock! Alberta Spring Investor Forum” will be featuring Aurora’s CEO, Terry Booth, as a speaker.
With regard to the Bakerview Business Borough in Bellingham, Washington, the Company’s wholly- owned subsidiary, Australis Capital Inc., is pleased to announce that this project has progressed with the signing of a Memorandum of Understanding with AJR Builders Group. This signing is another step towards developing Australis Holdings LLP’s plans in the creation of the best multifaceted project in Washington State that will exclusively cater to the recreational and medical cannabis industry.
- Published in Blog, Medical Marijuana
Aurora Cannabis (ACB:CSE) Milestones and Objectives for Success
Aurora Cannabis Inc. Setting up to become a Top Marijuana Producer in North America
With a full license to produce up to 5,500 Kilograms/year and a state-of-the-art, purpose-built facility exceeding governmental expectations, Aurora Cannabis Inc. is a promising Canadian marijuana producing company. With sound market strategies, Aurora intends to increase its production facility to 50,000 square feet every 1,5 years.
Aurora’s milestones since the beginning of 2015
• January 26, 2015 – Completion of the 55,200 square foot brand new facility in Mountain View County, Alberta.
• February 20, 2015 – Aurora received the federal license to produce medical marijuana under the Marijuana for Medical Purposes Regulations. Among the few organizations in Canada, Aurora is also the sole licensed producer within Alberta -Canada’s most business-friendly province. While the application was being processed, Aurora’s scientific team was organizing meetings with leading botanists from around the world, and developed a patent-pending pest control system.
• March 10, 2015 – Appointment of Dr. Jason Dyck, PhD, to its Board of Directors. Dr. Dyck specializes in the molecular biology of heart disease and metabolism. He is a leader in his field and has extensive experience in drug discovery and commercialization.
Important developments in the US
“Weed 3: The Marijuana Revolution”, a CNN documentary aired on April 19| 2015, explores the politics of medical marijuana research in the US. Dr. Sanjay Gupta interviewed President Barack Obama, who showed his support for the Careers Act of 2015. He also declared on record that it would be appropriate to follow science vs ideology and treat drug abuse issues from a public health model, as opposed to an incarceration model.
The Act, if passed, will entail the following for the marijuana industry:
• states will be able to legalize medical marijuana use without federal interference
• increase research on the medical benefits
• alter marijuana’s status as “dangerous drug”
US Marijuana market forecast
- Existing demand drives rapid growth from $1.5 billion in 2013 to $2.7 billion in 2014 – a 74{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} increase in one year
- It is expected to grow to $3.5 billion – an additional 32{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} in 2015
What this means for Aurora Cannabis Inc.?
In March 2015, Aurora Cannabis Inc. opened Australis Capital Inc. – a wholly owned subsidiary focused on opportunities in the United States with respect to production, processing, extracting of derivatives, and sale of both medicinal and recreational cannabis.
On April 7, 2015 Aurora Cannabis Inc., through Australis Capital Inc., made an agreement with AJR Builders Group LLC (Bellingham, Wash.), to form Australis Holdings LLP. Under this partnership, Australis will develop and construct a new marijuana production and processing facility on the 24.5 acres in the Bakerview Business borough (Whatcom County, Wash.). The site will be largest industrial development catering to the cannabis industry in Washington. (Read full description).
- Aurora will provide training, quality control, operation manuals and technical support for a number of turnkey production facilities;
- Operations in the state of Washington will facilitate expansion plans to serve recreational and medical marijuana markets in other American states.
Considering the imminent possible changes in the US legislation, paired with Canadian regulatory environment implemented as the Aurora standard, Aurora Cannabis has the potential for extensive market-defining impact.
Objectives and strategies for success
• Capture the majority of the market share.
• Adapt to changes in laws and markets.
• Expand activities beyond North America.
• Extensive marketing campaigns and set a different tone to the “marijuana” conversation.
• Create strategic partnerships with the marijuana scientific communities.
We encourage you to visit Aurora Cannabis website and view the Company’s investor presentation.
With their license now official, this creative energy can now be directed to producing the highest quality Medical Marijuana possible.
- Published in Blog, Medical Marijuana
Aurora Cannabis (ACB:CSE) to build Marijuana Production Plant in Washington State
AURORA CANNABIS SIGNS DEAL TO CONSTRUCT A NEW CANNABIS PRODUCTION AND PROCESSING FACILITY IN WASHINGTON STATE
Aurora Cannabis Inc., through its wholly owned subsidiary, Australis Capital Inc., has entered into a partnership agreement dated April 7, 2015, with AJR Builders Group LLC of Bellingham, Wash., to form a limited liability partnership named Australis Holdings LLP to construct a new marijuana production and processing facility in the state of Washington.
Highlights:
- Partnership agreement with Australis
- Construct new Marijuana Production & Processing Facility
- Bakerview Business Borough catering to the Cannabis industry in Washington
- Aurora to provide training, quality control, operation manuals and technical support for a number of turnkey production facilities.
- Operations in the state of Washington will facilitate expansion plans to serve recreational and medical marijuana markets in other US states.
Australis has recently acquired two (2) parcels of land totaling 24.5 acres in Whatcom County, WA in an area designated as the Bakerview Business Borough. The intention of Australis is to develop and construct a new marijuana production and processing facility utilizing the skills and experience of AJR. AJR has experience and a proven track record in developing facilities ideal for growing marijuana. The business park is situated in an I-502 approved area for recreational and medical marijuana businesses. The joint venture between ACI and AJR gives Australis exclusive development rights to develop a marijuana production and processing facility.
Located in the heart of Bellingham’s light industrial submarkets, the Bakerview Business Borough will be the largest, fully entitled, industrial development catering to the cannabis industry in Washington. When fully built out, the business park represents an opportunity of over a million square feet of production, processing and retail space. The area includes a dedicated space for a flagship processing facility for Australis that will further the “Aurora Standard”. Plans are currently in place for a sports bar, several restaurants, a rock climbing facility, a local microbrewery and craft distillery, and marijuana industry related supply stores. Multiple undisclosed celebrity brands of cannabis will be produced in the park along with a celebrity branded Vapor lounge. Each production facility space will offer a turnkey solution and I-502 licensees that lease these facility spaces will benefit from being able to grow in accordance with the renowned Aurora Standard – a production model synthesized from Canada’s global-leading health & safety standards along with experience from Aurora’s curated cannabis advisory team. Aurora will provide training in cultivation to ensure sanitary conditions and products (whole bud or extracts) are competitive quality-wise in any market, standard operating procedures and cutting edge technical support to the producers as part of a turnkey package. With an existing 12,500 sq. ft. warehouse and utilities on site, the first production warehouse will be available for occupancy in the summer of 2015, while work is conducted on the engineering and infrastructure for the remaining site.
Australis will organize tours of the production facilities by way of specific viewing areas, making this not only a multifaceted cannabis community but also an educational, exciting destination spot experience for tourists and locals. Nestled at the base of Mount Baker, the Bellingham area saw tourists spend $573.9 million dollars in 2013, many of whom are Canadians. Only 40 minutes from Vancouver and 90 minutes from Seattle, the Bakerview Business Borough is in a prime location to attract a high number of cannabis enthusiasts, and those curious about cannabis from both major cities. Tenants will be five minutes from Bellingham International Airport and 10 minutes from downtown. The port of Seattle is 90 miles south and a new deep-water port is being constructed just 30 miles away. Follow this link to view a video of the property: https://vimeo.com/112839760 (The password is “Mary”).
“We are looking forward to leveraging Aurora’s knowledge and cutting edge science to capitalize on Washington States recreational and medical marijuana markets,” said Jason Ragsdale, managing director of AJR Builder’s Group. “The planned project includes a state of the art processing facility and a variety of grow options including Hoop Houses, high-tech green houses and efficient indoor production facilities. These production facilities will be leased to serious 502 license holders under a turnkey situation. All producers will be expected to uphold the Aurora Standard as it pertains to the recreational and medical markets in Washington. ACI will provide the necessary resources to ensure that standard is being followed thus furthering their brand and reputation. Many license holders see the need for this type of partnership, the concept of multiple cannabis producers and processors in one location will give our partnership the ability to cultivate the highest quality strains of cannabis. We can start generating revenues within 90 days.”
“We believe that the advancement of our operations in the State of Washington will facilitate the Company’s strategic growth and expansion plans to serve the growing recreational marijuana market south of the border. Jurisdictions in the United States that we are presently focused on include Alaska, Oregon, Washington, Colorado, and Washington D.C. Nevada and California are also being looked at very closely as both states have recreational marijuana bills on their ballots for 2016,” commented Terry Booth, CEO of Aurora.
Washington Initiative 502 (I-502) for the legalization of recreational marijuana and marijuana related products for adults 21 and over appeared on the general ballot in November 2012. The initiative passed with a significant percentage of the vote, and was credited with producing the highest voter turnout in the nation at an astounding 81{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}. The result of I-502’s successful ratification has been a new and flourishing industry for every aspect of marijuana cultivation, extraction, processing, packaging, and sales. The recently passed Senate Bill 6062 changes end users’ tax from 75{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} to 37{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}. Another bill passed by Washington legislature, SB 5052, will overhaul the states medical marijuana market. SB 5052 will eliminate the allowance of up to 300 unregulated dispensaries that have operated in the state for years. This bill will cause many consumers to move to the new regulated recreational market and will also raise the standard of quality in the medical market. Significant positive changes in the regulation of recreational and medical marijuana continue to occur at the time of this acquisition.
The 24.5 acres of land were purchased for a price of USD $2.3 million. ACI has provided an initial funding of approximately CAD $1.6 million by way of a secured loan to Australis.
Subject to shareholder approval the Company intends to spin out ACI under a Plan of Arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”), pursuant to which shares of ACI will be distributed to the holders of common shares of Aurora on a pro-rata basis. The directors of the Company believe that the creation of two separate public companies, one focused in Canada and one focused in the U.S. and international markets will enhance their respective business operations and provide shareholders of Aurora with diversified investment choices. The Company will announce the details of the Arrangement in due course. There can be no assurances or guarantees that the Arrangement will be completed or approved by the exchange.
- Published in Blog, Medical Marijuana
Nomad Ventures (NMD:CSE), Ivancoe Purchase Agreement
Nomad Ventures, Ivancoe agreement
2015-04-20- News Release – Equipment Purchase Agreement
The TSX Venture Exchange has accepted for filing an asset purchase agreement dated April 14, 2015, between Nomad Ventures Inc. and Shane Ivancoe, whereby the company will purchase a 30-ton capacity crane, six steel pipes, barge winches and 10-ton anchors for use on its St. Vincent Bay property. Consideration is 1,123,500 common shares.
Corporate Presentation
DealNet Chosen as Mobile Engagement Partner by Jim Pattison Broadcast Group
DealNet Capital Corp Chosen as Mobile Engagement Partner by Jim Pattison Broadcast Group for Edmonton Radio Station
News release – April 15, 2015 – DealNet Capital Corp. (“DealNet” or the “Company”) (DLS:CSE) is pleased to announce that its mobile engagement subsidiary, Impact Mobile, has signed an agreement with the Jim Pattison Broadcast Group’s (“JPBG”) Edmonton radio stations.
The agreement will provide JPBG’s radio stations the ability to “chat” with listeners via SMS, and to interact using contests, voting, and other mobile engagement techniques.
“We have worked with Impact Mobile in the past, and are pleased to sign this new agreement with them.” said Jamie Wall, General Manager of JPBG in Edmonton. “They’ve proven to be a valuable partner, and we’re confident we’ll be able to expand the relationship with our audiences.”
“We’re very pleased to sign this new contract. We are already working to enhance the services that we provide to JPBG, recognizing that JPBG is trusting us to make sure they have access to the most innovative and robust mobile engagement solutions in the market”, said Mike Hilmer, COO, Interim President and CEO of DealNet.
About DealNet Capital Corp.
Dealnet Capital Corp. focuses on two key vertical markets, Consumer Engagement and Consumer Finance. Through acquisitions, the Company has become a leader in the Consumer Engagement space helping their corporate customers ‘speak’ to their consumers the way they want to be spoken to using live Voice, Chat, Text, Email and Proximity based engagement solutions. The Company has leveraged its engagement business to offer home improvement financing solutions to consumers, which offer attractive yields and low default rates. The Company continues to seek acquisitions in these key markets.
InMed Awarded Mitacs Grant for Proprietary Glaucoma Therapy
INMED AWARDED GRANT FOR PROPRIETARY NANOPARTICLE-BASED DELIVERY SYSTEM FOR GLAUCOMA THERAPY
News Release – April 15, 2015 – InMed Pharmaceuticals Inc. (“InMed”) (CSE: IN; OTCQB: IMLFF), a clinical stage biopharmaceutical company that specializes in developing safer, more effective cannabinoid-based therapies, today announced that it has been awarded a grant to further develop the Company’s proprietary nanoparticle-based delivery system for their leading drug candidate CTI-085 for glaucoma. Initial formulation, in vitro & in vivo development is currently underway in collaboration with members of the Department of Chemical & Biological Engineering at the University of British Columbia. The grant from Mitacs, a leading Canadian non-profit organization that accelerates innovative projects through strategic academic and industry collaboration, is partially funding the ongoing development of the delivery system and is the second grant awarded to InMed from Mitacs.
The Mitacs grant was awarded to Dr. Maryam Kabiri, Ph.D., a researcher with extensive experience in developing nanoparticle-based delivery systems. Dr. Kabiri will be working with Prof. Vikramaditya G. Yadav, whose research focuses on metabolic & enzyme engineering and customized novel biosynthetic enzymes that can convert biomass-derived feedstock into better fuels, pharmaceuticals and value-added chemicals. In conjunction with InMed, the Mitacs grant will be utilized to develop a novel delivery system for glaucoma therapy.
Dr. Sazzad Hossain, Chief Scientific Officer, states, “We are pleased to have met the Mitacs funding criteria for the advancement of our proprietary glaucoma delivery system. Not only does this bring us closer to our goals of initiating our Phase 1 trial, but it furthers our business development strategy of having a proprietary delivery system that can be licensed with existing drugs endangered by patent expiration. This “therapy extension” strategy used by drug makers can be a valuable asset to InMed upon successful completion of the program. Additionally, the incorporation of an existing medicine into a new drug delivery system can significantly improve its performance in terms of efficacy, safety, and improved patient compliance.”
About Mitacs
Mitacs is a national, private not-for-profit organization that develops the next generation of innovators with vital scientific and business skills through a suite of unique research and training programs, such as Mitacs-Accelerate, Elevate, Step, Enterprise and Globalink. In partnership with companies, government and universities, Mitacs is supporting a new economy using Canada’s most valuable resource – its people.
For more information on Mitacs, visit www.mitacs.ca.
About InMed
InMed is a clinical stage biopharmaceutical company that specializes in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the Company.
- Published in Blog, Life Sciences, Medical Marijuana
DealNet (DLS:CSE) Provides Business Update and Organizational Changes
DealNet Provides Business Update and Organizational Changes
April 8, 2015 – News Release – DealNet Capital Corp. (“DealNet” or the “Company”) (DLS:CSE) is pleased to provide the following business update and organizational changes.
The Company operates under two main divisions, consisting of Consumer Engagement and Consumer Financing. The Consumer Engagement division consists of two wholly owned subsidiaries, OC Communications Group Inc. (“OCCGI”) and Impact Mobile Inc. (“Impact Mobile”). This division helps corporate clients ‘speak’ to their customers the way customers want to be spoken to, utilizing a range of technologies including live voice, chat, text, email and proximity based engagement solutions. By moving live call engagements to other platforms, including mobile messaging engagements, the Company is able to reduce operating costs for its corporate clients, increase consumer satisfaction and drive higher margins from each customer engagement. The Consumer Engagement division has operations in both Canada and the United States.
The Consumer Financing division operates through a wholly owned subsidiary, One Dealer Financial Services Inc. (“ODFSI”). The Company has leveraged OCCGI’s Consumer Engagement business to offer home improvement financing solutions to consumers, which offer attractive yields supported by low default rates.
Over the last several months, Management has undertaken a number of initiatives to:
- Align the business for further growth with expanded and integrated services
- Consolidate acquired sales and delivery functions
- Reduce financing and overhead costs
- Strengthen the Company’s financial position
- Strengthen board and management with key additions
The Company is pleased to report progress in all areas.
Conversion of Convertible Debentures
On December 16, 2014, the Company announced an incentive plan in an effort to entice holders of the Company’s 12{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} convertible debentures maturing in December 2015 to convert their debentures on or before December 31, 2014. Of the $2,415,000 convertible debentures outstanding prior to the announcement of the incentive plan, $2,140,000 (or 89{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the outstanding debt) was converted. This conversion improves the Company’s financial position and eliminates cash interest expenses of approximately $250,000 in the 2015 fiscal year.
Closing of Non-Brokered Private Placement
As announced on November 25, 2014, the Company embarked on a non-brokered private placement to raise up to $5 million in new equity through cash and the settlement of existing debts of the Company. On February 11, 2015 and March 13, 2015, the Company closed the first and second tranches of this offering. To date, the Company has issued $3.1 million of equity, consisting of gross cash proceeds of approximately $1.2 million and the settlement of existing debts of the Company of approximately $1.9 million. The Company expects to complete one more closing in the coming weeks.
Closing of Secured Debenture for HVAC Leasing
On March 12, 2015, the Company announced the closing of a $3,000,000 three year debenture by its wholly owned subsidiary, ODFSI. The closing consisted of a single debenture by the wealth management arm of one of Canada’s largest life and health insurance companies. The investor has the option to invest up to $50 million under the offering at their discretion. Management believes this to be a significant closing following a year of discussions and due diligence by this reputable institution.
Changes to Board and Executive Team
On March 23, 2015, Mr. Robert Cariglia, agreed to step down from the position of President and CEO of the Company. Mr. Cariglia will continue to serve as a director of the Company. Pierre G. Gagnon, Chairman of the Company stated “We wish to thank Bob for his dedicated service and contributions to the Company during its formative years and look forward to his continued contributions at the Board level”.
Michael Hilmer, Co-Founder, Chief Operating Officer of the Company, will assume the role of Interim President and CEO of the Company.
Also on March 29, 2015, the Board of Director’s passed a resolution inviting Dr. Stephen Simms to join the board. Dr. Simms has over 25 years of hands-on experience in the private and public company arena. He has been involved with every aspect of corporate management and growth, from initial start-up to product development, commercialization and sales. He has worked on corporate finance, business and product development, financial management, merger & acquisition reviews, infrastructure projects, financial forecasts, cash flows, budgets, financial analysis, project management and executive management.
On January 15, 2015, Gary Martin joined the Company as Senior Vice President, Sales and Marketing. Gary, who began his career at IBM, brings over two decades of global technology sales and leadership experience to DealNet. He has held senior sales and leadership roles with leading companies in the technology and business process outsourcing industry including: DMR Consulting Group, Changepoint, TELUS, PwC, and most recently Accenture. Throughout his career, he has worked with global clients across a number of industry sectors helping them maximize their return on investments in technology.
Major Contract Wins in Consumer Engagement Division
The Consumer Engagement business continues to thrive with growth from existing customers and new customer engagements:
- In the fall of 2014, OCCGI successfully launched a five-year agreement with a leading Canadian insurance company to provide service desk support with minimum revenues to OCCGI of $1.2M.
- In the fall of 2014, Impact Mobile entered into a multi-year agreement to provide a mobile marketing platform to a major weather network allowing the network to run self-service mobile engagement programs with its partner brands.
- In February 2015, OCCGI was successful in renewing and expanding outsourcing support for a strategic North American based energy retailer.
- In March 2015, OCCGI was successful in renewing a two-year outsourcing contract with a client in the safety regulation industry in Ontario with minimum revenues to OCCGI of $864K over two years.
- In March 2015 Impact Mobile signed an agreement to provide messaging connectivity into Canada for a major international messaging gateway provider. The gateway provider currently routes millions of SMS messages per month into Canada for banks, consumer brands, mobile marketing corporations, and other enterprise clients. The contract with Impact Mobile includes the migration of this existing messaging as well as future traffic, which is expected to expand to include multimedia messaging (MMS).
- OCCGI is realizing organic growth within existing contracts. In July 2013, OCCGI announced a five-year, $10 million ($2 million annually) contract with a Fortune 500 financial services client in the United States to provide inbound customer service in English and Spanish. The support went live in September 2013 and revenue for the first year of the contract was in excess of $4.6 million. The client is also entertaining additional proposals from our Consumer Engagement team including products and services provided by Impact Mobile as part of our overall engagement solutions.
Enhanced Product Offerings
- The launch of our Proximity and Analytics Engagement Solution is complete and new branding is expected to be launched in the spring of 2015 to simplify the market messaging. New alliances have been forged with best-of-breed networking and infrastructure companies that provide a component of our engagement solution and wish to sell through our solutions to their customers. Formalization of these relationships is expected later in 2015.
- In November 2014, Impact Mobile expanded mobile marketing operations into Brazil to service the needs of leading international brands. The technical work has been completed to support the launch of a major sports brand by June 2015.
- In December 2014, Impact Mobile successfully provisioned and launched Canada’s first Next Generation 3-1-1 (NG3-1-1) Service with the City of Windsor, Ontario as the anchor municipality allowing residents to have two-way texting communication for a full range of services and informational options across any carrier network nationally.
- In February 2015, Impact Mobile successfully provisioned and launched Canada’s first Next Generation 2-1-1 (NG2-1-1) Service with the BC Services Society call centre allowing residents of the Lower Mainland to access BC2-1-1 services by texting 211 from their mobile device. This allows the public to access free information and referrals regarding social services in BC with a text message.
Consumer Financing:
- ODFSI has added over 23 dealers since the soft launch of the business in the second half of 2014 and continues to grow its dealer base selectively and quickly.
- With new access to institutional financing, ODFSI has accelerated the dealer onboard process in anticipation of increased volume and deal flow including increasing the size and volume of the dealers being added. The Company is in discussions with multiple underwriters to ensure maximum capacity to support anticipated consumer rental contract volumes.
- Since September 2014, the Company has been processing regular weekly deal flow often with several deals daily and expects to scale that volume significantly in Q2.
- Loan defaults to date on deals funded in 2014 were less than anticipated and below underwriter requirements.
- Launched new white label funding program to support dealer supplied equipment and homeowner solutions and received positive feedback on pricing and demand leading to increased interest from the dealer community.
Other Corporate News
- In the fall of 2014, the Company launched its new website, www.dealnetcapital.com, which focuses on the Company’s two primary verticals, Consumer Engagement and Consumer Financing.
- Integration of Impact Mobile into Consumer Engagement business is substantially complete. Common functions have been integrated and several joint engagement initiatives are being worked on including various strategic initiatives and partnerships that are significant in value and expected to close in 2015.
- The Company has built a large sales pipeline of opportunities that have been bid on, shortlisted or are in various stages of discovery, supporting the combined Consumer Engagement messaging in the market. The Company expects to win new business in 2015 under long term contracts.
About DealNet Capital Corp.
Dealnet Capital Corp. focuses on two key vertical markets, Consumer Engagement and Consumer Finance. Through acquisitions, the Company has become a leader in the Consumer Engagement space helping their corporate customers ‘speak’ to their consumers the way they want to be spoken to using live Voice, Chat, Text, Email and Proximity based engagement solutions. The Company has leveraged its engagement business to offer home improvement financing solutions to consumers, which offer attractive yields and low default rates. The Company continues to seek acquisitions in these key markets.
InMed Pharmaceuticals arranges $1-million financing
2015-04-06 11:25 ET – News Release
Mr. Craig Schneider reports
INMED PHARMACEUTICALS, INC. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT FOR UP TO C$1,000,000
InMed Pharmaceuticals Inc. will conduct a non-brokered private placement of up to four million units at a price of 25 cents per unit for aggregate gross proceeds of up to $1-million. Each unit will consist of one common share and one-half of one non-transferable share purchase warrant. Each whole warrant will be exercisable by the holder to acquire one additional common share at a price of 40 cents for a period of 12 months following the closing of the financing.
Completion of the private placement is subject to receipt of regulatory approval. All securities issued will be subject to a statutory four-month hold period under applicable securities laws.
The net proceeds from this private placement will be used for general working capital purposes. Finders’ fees in cash or warrants may be payable in accordance with the policies of the exchange.
We seek Safe Harbor.
- Published in Blog, Life Sciences